Botox

Botox is a very well-characterized pure, safe, protein product that when injected into muscle reduces transmission of acetylcholine at the neuromuscular junction. It thereby relaxes the same muscle – for up to months at a time. It’s that simple.

Unfortunately, Botox is often recognized by the general public as a rather frivolous product whose sole use is to remove wrinkles.

Nothing could be further from the truth. Botox has been FDA-approved for over 25 years for many serious conditions including blepharospasm (involuntary spasm of the muscles around the eyes) and torticollis (involuntary spasm of neck muscles), where it has proven revolutionary in improving the lives in those who suffer from these conditions.

In addition, Botox can be used for hyperhidrosis (excessive sweating), hypersalivation (the drooling seen in some Parkinson patients), spasticity, and spastic bladder. The latest FDA-approved use is for chronic migraine headaches (see Neurological Conditions).

Dr. Hutchinson has over 19 years experience with Botox, and routinely injects it for headache, blepharospasm, torticollis, hypersalivation and hyperhidrosis.

At New York Core Neuroscience, we achieve an average 89% reduction in headache frequency using Botox. This result is far superior to the results of the original Allergan study, where there was an average 40% reduction. Moreover, in our hands almost half (44%) of those with daily migraines obtain complete resolution of the headaches. In almost every case where there are residual headaches, these are not only much less frequent, but also much less severe and easy to deal with using simple medications. We attribute our results to the fact that we do not use a standard template of injection sites, but individualize each patient.

Michael Hutchinson, MD

Neurologist located in New York, NY

Michael Hutchinson MD, PhD is a neurologist at New York Core Neuroscience serving patients in New York, New York. A graduate of the highly competitive PhD-to-MD program at the University of Miami, Dr. Hutchinson received his medical degree in 1988. During his residency training at the University of Washington, he developed a method of treating status epilepticus (the most lethal form of epilepsy) that is now the standard of care in the US. In addition to extensive training in multiple sclerosis, Dr. Hutchinson completed a two-year fellowship in neuroimaging at UCLA. He is currently Senior Faculty  at the Icahn School of Medicine at Mount Sinai, New York.

Dr. Hutchinson is board certified in both neurology and neuroimaging and is President of the American Society of Neuroimaging. He holds a PhD in molecular physics in addition to his medical degree. A medical pioneer, Dr. Hutchinson proposed a novel treatment for status epilepticus in 1990, now the standard of care. He was the first to use cholinesterase inhibitors for the dementia of Parkinson’s disease (1995) and developed a novel approach to treating acute relapses in multiple sclerosis (2002). He is the inventor of the parallel MRI (1987), which is now the world standard for magnetic resonance imaging.

Read more
New York Core Neuroscience

Michael Hutchinson MD, PhD is a neurologist at New York Core Neuroscience serving patients in New York, New York. A graduate of the highly competitive PhD-to-MD program at the University of Miami, Dr. Hutchinson received his medical degree in 1988. During his residency training at the University of Washington, he developed a method of treating status epilepticus (the most lethal form of epilepsy) that is now the standard of care in the US. In addition to extensive training in multiple sclerosis, Dr. Hutchinson completed a two-year fellowship in neuroimaging at UCLA. He is currently Senior Faculty  at the Icahn School of Medicine at Mount Sinai, New York.

Dr. Hutchinson is board certified in both neurology and neuroimaging and is President of the American Society of Neuroimaging. He holds a PhD in molecular physics in addition to his medical degree. A medical pioneer, Dr. Hutchinson proposed a novel treatment for status epilepticus in 1990, now the standard of care. He was the first to use cholinesterase inhibitors for the dementia of Parkinson’s disease (1995) and developed a novel approach to treating acute relapses in multiple sclerosis (2002). He is the inventor of the parallel MRI (1987), which is now the world standard for magnetic resonance imaging.


Read less
Services

Services

Affiliations

Accepted Insurance Providers

Our medical practice works closely with numerous insurance carriers to ensure that our patients get the care that they need and deserve. If you have any questions or do not see your insurance carrier listed, please contact our office directly. We now accept Oscar Commercial Insurance, and effective as of October 1st, Dr. Hutchinson is in-network with HIP Medicare Advantage and HIP commercial plans.

  Regence Blue Cross Blue Shield
1199SEIU
AARP
Aetna
Anthem Blue Cross
Anthem Blue Cross Blue Shield
Arkansas Blue Cross Blue Shield
Assurant Health
Blue Cross Blue Shield
Blue Cross Blue Shield of Florida (Florida Blue)
Blue Cross Blue Shield of Illinois
Blue Cross Blue Shield of Kansas
Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Texas
Blue Cross of Idaho
Blue Cross of Northeastern Pennsylvania
Testimonials

Words from our patients

  • Yelp

    "Finding Dr. Hutchinson has saved my life from migraines that I have suffered from all my life. I love him! I highly recommend him to anyone who needs a neurologist."

    Lisa M.
  • Yelp

    "Dr. Hutchinson is a great physician. He takes time with his patients and really listens to his patients - which is a rarity today in health care!"

    Christine S.
Ask us

Feel free to email us regarding any scheduling or general questions!

Follow Us
Hours

Michael Hutchinson, MD
345 East 37th Street
Suite 320
New York, NY 10016